The Food and Drug Administration has approved Boehringer Ingelheim Pharmaceuticals' single-pill antiretroviral for HIV-1 patients, BI said Tuesday.
Generic drug maker Impax Labs is hoping to become the first to market a version of a gastroesophageal reflux disease treatment made by Takeda Pharmaceutical.
Frito-Lay is spicing up its Doritos, Fritos and Ruffles brands with a zesty offering.
Mylan subsidiary Bioniche Pharma has launched an injectable treatment for a rare metabolic disorder, Mylan said Tuesday.
French skin care brand Vichy Labs will launch in May its new ProEven total dark spot corrector, a formula with DeeperCell-concentrate designed to help address dark spots and uneven skin tone.
CandyRific is boosting Mike and Ike candy offerings with new items.
Canadian drug maker Intellipharmaceutics International is seeking approval for a generic version of a treatment for mental disorders.
A new functional beverage that promises to help curb hangovers is hitting the market.
A topical medication for treating low testosterone in men now is available, drug maker Eli Lilly said.
Pepsi is gearing up to launch a low-calorie soft drink, according to published reports.